Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients.

BACKGROUND Although a controversial and complex issue, the prognostic factors of skull base chordomas are worth exploring. METHODS Prognostic factors associated with overall survival (OS) were retrospectively estimated in an individual cohort of skull base chordomas prospectively maintained for 10 years by a Kaplan-Meier method and univariate Cox proportional hazards model. Multivariate analysis by Cox regression analysis was performed to identify the independent prognostic factors. A nomogram was then formulated by R software based on the results. RESULTS A total of 180 primary patients and 45 recurrent cases were included, with a mean follow-up period of 43.7 months (range, 4-127 months). The OS of the primary group at 5 years and 7 years was 84% and 78%, and the mean OS was 103.8 months, which was significantly longer than the recurrent group, in which the mean postrecurrent OS was 68.4 months. In the primary group, preoperative Karnofsky Performance Status (KPS) score (P = 0.004) and a decline of perioperative KPS score (P = 0.015) were identified as independent predictors of OS. A nomogram was contracted to predict 5-year, and 7-year OS, which was well calibrated and had good discriminative ability (adjusted Harrell C statistic, 0.74). In the recurrent group, visual deficit was verified as an independent risk factor associated with postrecurrent OS (P = 0.014). CONCLUSIONS Both pathologic and perioperative KPS score evaluations are significant in OS prediction of both primary and recurrent cases. The nomogram for primary lesions, consisting of preoperative functional status and its perioperative changes, appears useful for risk stratification of long-term survival.

[1]  Liwei Zhang,et al.  Analysis of Clinical Features and Outcomes of Skull Base Chordoma in Different Age-Groups. , 2016, World neurosurgery.

[2]  I. Yang,et al.  Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma , 2010, Journal of Neuro-Oncology.

[3]  A. Samii,et al.  Chordomas of the skull base: surgical management and outcome. , 2007, Journal of neurosurgery.

[4]  I. Yang,et al.  A comprehensive analysis of intracranial chordoma and survival: a systematic review , 2011, British journal of neurosurgery.

[5]  Scott M Schuetze,et al.  Chordoma: the nonsarcoma primary bone tumor. , 2007, The oncologist.

[6]  B. Nahed,et al.  Chordoma: current concepts, management, and future directions. , 2012, The Lancet. Oncology.

[7]  H. Vinters,et al.  Predictors of recurrence following resection of intracranial chordomas , 2015, Journal of Clinical Neuroscience.

[8]  D. Choi,et al.  Outcome of 132 Operations in 97 Patients With Chordomas of the Craniocervical Junction and Upper Cervical Spine , 2010, Neurosurgery.

[9]  J. Holton,et al.  Skull base chordomas: correlation of tumour doubling time with age, mitosis and Ki67 proliferation index , 2000, Neuropathology and applied neurobiology.

[10]  J. Buatti,et al.  Disease outcomes for skull base and spinal chordomas: A single center experience , 2015, Clinical Neurology and Neurosurgery.

[11]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[12]  J. Godbold,et al.  Clival chordomas: clinical management, results, and complications in 71 patients. , 2010, Journal of neurosurgery.

[13]  Jie Tang,et al.  Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas—106 cases review in one institution , 2010, Neurosurgical Review.

[14]  D. Ramanathan,et al.  Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies. , 2011, Journal of neurosurgery.

[15]  A. Carpentier,et al.  Suboccipital and cervical chordomas: the value of aggressive treatment at first presentation of the disease. , 2002, Journal of neurosurgery.

[16]  S. Stacchiotti,et al.  Building a global consensus approach to chordoma: a position paper from the medical and patient community. , 2015, The Lancet. Oncology.

[17]  Jiang Du,et al.  Factors for tumor progression in patients with skull base chordoma , 2016, Cancer medicine.

[18]  D. Kondziolka,et al.  Stereotactic Radiosurgery for Chordoma: A Report From the North American Gamma Knife Consortium , 2011, Neurosurgery.

[19]  O. Al-Mefty,et al.  Chordomas of the craniocervical junction: follow-up review and prognostic factors. , 2001, Journal of neurosurgery.

[20]  Liang Wang,et al.  Clinical and pathological features of intradural retroclival chordoma. , 2014, World neurosurgery.

[21]  C. Compton,et al.  A uniform residual tumor (R) classification , 2009, Cancer.

[22]  J. Tonn,et al.  Male sex as a risk factor for the clinical course of skull base chordomas. , 2014, Journal of neurosurgery.

[23]  W. Curry,et al.  Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database , 2014, Journal of Clinical Neuroscience.

[24]  S. Henderson,et al.  Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas , 2006, The Journal of pathology.

[25]  John Y. K. Lee,et al.  Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis. , 2014, World neurosurgery.

[26]  Janice,et al.  A multidisciplinary team approach to skull base chordomas. , 2001, Journal of neurosurgery.

[27]  R. Pallini,et al.  Chordoma of the skull base: predictors of tumor recurrence. , 2003, Journal of neurosurgery.

[28]  B. Eriksson,et al.  Chordoma: A Clinicopathologic and Prognostic Study of a Swedish National Series , 1981 .

[29]  O. Al-Mefty,et al.  Skull base chordomas: a management challenge. , 1997, Journal of neurosurgery.

[30]  E. Aronica,et al.  Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors , 2016, Journal of neuropathology and experimental neurology.

[31]  B. Scheithauer,et al.  Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. , 1993, Journal of neurosurgery.

[32]  Oliver Jäkel,et al.  Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: First long‐term results , 2014, Cancer.